cuprizone has been researched along with fluorodeoxyglucose f18 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brendel, M; Chrzanowski, U; Eckenweber, F; Fabisch, KH; Hecher, K; Hochstrasser, T; Kipp, M; Rühling, S; Sacher, C; Schmitz, C | 1 |
| Branton, WG; Doan, MAL; Fernandes, JP; Major, EO; Monaco, MC; Power, C; Saito, LB; Schmitt, LM; Smith, MJ; Wuest, F; Wuest, M | 1 |
2 other study(ies) available for cuprizone and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Stereological Investigation of Regional Brain Volumes after Acute and Chronic Cuprizone-Induced Demyelination.
Topics: Animals; Atrophy; Brain; Chelating Agents; Cuprizone; Fluorodeoxyglucose F18; Male; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Positron-Emission Tomography; Radiopharmaceuticals | 2019 |
Intranasal anti-caspase-1 therapy preserves myelin and glucose metabolism in a model of progressive multiple sclerosis.
Topics: Animals; Caspase 1; Cuprizone; Disease Models, Animal; Fluorodeoxyglucose F18; Glucose; Humans; Inflammation; Mice; Mice, Inbred C57BL; Multiple Sclerosis, Chronic Progressive; Myelin Sheath | 2021 |